Health
US vaccine hopeful of using Gates Foundation cash to prepare for human trial – Hindustan Times
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising…
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their Covid-19 vaccine candidate toward 2021 human trials.
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage.
“We believe there is real potential,” Vandenberghe…
-
Noosa News21 hours agoAnimal Welfare Notices issued to SA’s Andgar Piggery after 14 euthanased by RSPCA
-
General23 hours agoThe ‘critical’ data that could greenlight next rate cut
-
Noosa News22 hours agoElite Brisbane private girls college All Hallows’ School closes after ‘significant event’
-
General22 hours agoReport finds 2032 Brisbane Olympic and Paralympic Games could bring $70 billion in economic opportunities